ALERT

We now accept walk-ins at designated COVID-19 sites during vaccination days and hours. You may still schedule your vaccination if you choose, or walk up to our mobile vaccination clinic which is open to everyone! Note: we require masks in all St. Luke's facilities, regardless of COVID-19 vaccination status. This helps us provide safe care in a safe environment for all patients. Access more information on COVID testing, visitor policy, safety practices, hospitalization data, and FAQs.

toggle mobile menu Menu
toggle search menu

Site Navigation

Supplemental

Menu

Blood and Marrow Transplant

Article

Autologous Stem Cell Transplant

Blood and Marrow Transplants, Close to Home

The Blood and Marrow Transplant (BMT) and Hematologic Malignancies program at St. Luke’s Cancer Institute is the first and only one of its kind in Idaho. Our patients receive the region’s most advanced therapies, with the benefit of care close to home.

Studies show that patient outcomes in community transplant programs, such as St. Luke’s Cancer Institute - Center for Blood Cancer Therapy, are equal to those at academic medical centers. Moreover, our patients tell us that their quality of life is better because they’re able to stay close to home and family. We are committed to working with patients and physicians throughout every stage of the transplant process, and to returning patients home as soon as possible.

Since 1993, St. Luke's Cancer Institute has been performing autologous transplants (using the patient’s own stem cells) and syngeneic transplants (using cells from an identical twin). We also perform allogeneic transplants (using cells from a matched donor). Like other recognized centers around the country, our team uses mobilized peripheral blood stem cells in the transplant process. Our facility is a National Marrow Donor Program (NMDP) apheresis center. 

Article

Allogeneic Stem Cell Transplant

BMT Program Details

We offer you:

  • A highly trained multidisciplinary team of care providers, including specially trained physicians, nurses, social workers, dietitians, and others
  • An on-site, full-service BMT lab that performs the collection, cryopreservation, and storage of all stem cell products
  • The advantages of participation in national clinical trials and cooperation with regional academic and research centers
  • The benefits of a facility accredited by the Foundation for the Accreditation of Cellular Therapy (FACT), a national non-profit organization that promotes high-quality patient care and quality laboratory performance.

Who is a candidate for BMT at St. Luke’s Cancer Institute?

When referred by their oncologist, we treat adult and pediatric patients. 

  • Autologous transplants for adult patients: lymphomas and Hodgkin’s disease, multiple myeloma, and some testicular cancers
  • Autologous transplants for pediatric patients: neuroblastoma, lymphomas, Hodgkin’s disease, medulloblastoma, and germ cell tumors 
  • Allogeneic transplants for adult patients: acute leukemia, myelodysplastic syndrome, myelofibrosis, certain lymphomas, and other bone marrow cancers
For more information about referral to our program, call (208) 381-2711 or toll free 1-800-845-4624.

Additional Blood and Marrow Transplant Resources

Support Groups

  • showing 1 of 1

Articles & Resources

  • showing 4 of 4